Learoyd D - Search Results

1

Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery.

Papachristos AJ, Nicholls LE, Mechera R, Aniss AM, Robinson B, Clifton-Bligh R, Gill AJ, Learoyd D, Sidhu SB, Glover A, Delbridge L, Sywak M. Papachristos AJ, et al. Among authors: learoyd d. Oncologist. 2023 Dec 11;28(12):1064-1071. doi: 10.1093/oncolo/oyad232. Oncologist. 2023. PMID: 37632760 Free PMC article.

2

Standard and emerging therapies for metastatic differentiated thyroid cancer.

O'Neill CJ, Oucharek J, Learoyd D, Sidhu SB. O'Neill CJ, et al. Among authors: learoyd d. Oncologist. 2010;15(2):146-56. doi: 10.1634/theoncologist.2009-0190. Epub 2010 Feb 8. Oncologist. 2010. PMID: 20142332 Free PMC article. Review.

3

BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.

O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS. O'Neill CJ, et al. Surgery. 2010 Dec;148(6):1139-45; discussion 1145-6. doi: 10.1016/j.surg.2010.09.005. Surgery. 2010. PMID: 21134544

4

Patterns of structural recurrence in papillary thyroid cancer.

Kruijff S, Petersen JF, Chen P, Aniss AM, Clifton-Bligh RJ, Sidhu SB, Delbridge LW, Gill AJ, Learoyd D, Sywak MS. Kruijff S, et al. Among authors: learoyd d. World J Surg. 2014 Mar;38(3):653-9. doi: 10.1007/s00268-013-2286-0. World J Surg. 2014. PMID: 24149717

5

New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.

Gosnell JE, Sywak MS, Sidhu SB, Gough IR, Learoyd DL, Robinson BG, Delbridge LW. Gosnell JE, et al. ANZ J Surg. 2006 Jul;76(7):586-90. doi: 10.1111/j.1445-2197.2006.03783.x. ANZ J Surg. 2006. PMID: 16813623

6

Surgical approach to medullary thyroid cancer.

Lundgren CI, Delbridg L, Learoyd D, Robinson B. Lundgren CI, et al. Among authors: learoyd d. Arq Bras Endocrinol Metabol. 2007 Jul;51(5):818-24. doi: 10.1590/s0004-27302007000500020. Arq Bras Endocrinol Metabol. 2007. PMID: 17891246 Review.

7

Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases?

Learoyd DL, Robinson BG. Learoyd DL, et al. Nat Clin Pract Endocrinol Metab. 2008 Mar;4(3):132-3. doi: 10.1038/ncpendmet0722. Epub 2007 Dec 11. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18073715 No abstract available.

8

Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer.

Learoyd DL, Robinson BG. Learoyd DL, et al. Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):6-7. doi: 10.1038/ncpendmet1020. Epub 2008 Nov 11. Nat Clin Pract Endocrinol Metab. 2009. PMID: 19002129 No abstract available.

9

Increasing incidence of thyroid cancer is due to increased pathologic detection.

Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L. Grodski S, et al. Among authors: learoyd d. Surgery. 2008 Dec;144(6):1038-43; discussion 1043. doi: 10.1016/j.surg.2008.08.023. Surgery. 2008. PMID: 19041015

10

Medullary thyroid carcinoma: long-term outcomes of surgical treatment.

Abraham DT, Low TH, Messina M, Jackson N, Gill A, Chou AS, Delbridge L, Learoyd D, Robinson BG, Sidhu S, Sywak M. Abraham DT, et al. Among authors: learoyd d. Ann Surg Oncol. 2011 Jan;18(1):219-25. doi: 10.1245/s10434-010-1339-y. Epub 2010 Sep 28. Ann Surg Oncol. 2011. PMID: 20878247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters